{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:21:09Z","timestamp":1790968869544,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DA046345-05W1"],"award-info":[{"award-number":["P30DA046345-05W1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01DA051709"],"award-info":[{"award-number":["K01DA051709"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA028874"],"award-info":[{"award-number":["T32DA028874"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AG076411"],"award-info":[{"award-number":["T32AG076411"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addiction Neuroscience"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.addicn.2026.100253","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:34:39Z","timestamp":1768718079000},"page":"100253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Hippocampal volume and brain tau pathology in opioid use disorder: Associations with non-fatal opioid overdose"],"prefix":"10.1016","volume":"19","author":[{"given":"Delaney","family":"McKinstry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5697-2034","authenticated-orcid":false,"given":"Zhenhao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid P.","family":"Ramos-Rol\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhitsu","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan M.","family":"Hager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Pond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora D.","family":"Volkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry R.","family":"Kranzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob G.","family":"Dubroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya M.","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinde E.","family":"Wiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.addicn.2026.100253_bib0001","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/MLR.0000000000001389","article-title":"The impact of various risk assessment time frames on the performance of opioid overdose forecasting models","volume":"58","author":"Chang","year":"2020","journal-title":"Med. Care"},{"issue":"1","key":"10.1016\/j.addicn.2026.100253_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.addicn.2026.100253_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108838","article-title":"Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: a systematic review","volume":"226","author":"Winstanley","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.addicn.2026.100253_bib0004","doi-asserted-by":"crossref","first-page":"76","DOI":"10.15585\/mmwr.mm6603a2","article-title":"Cluster of an unusual amnestic syndrome - massachusetts, 2012-2016","volume":"66","author":"Barash","year":"2017","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"issue":"12","key":"10.1016\/j.addicn.2026.100253_bib0005","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMc1716355","article-title":"Acute amnestic syndrome associated with fentanyl overdose","volume":"378","author":"Barash","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.addicn.2026.100253_bib0006","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/00952990.2016.1245312","article-title":"Gray matter abnormalities in opioid-dependent patients: a neuroimaging meta-analysis","volume":"43","author":"Wollman","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.addicn.2026.100253_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/00952990.2018.1517262","article-title":"Neuropsychological functioning in opioid use disorder: a research synthesis and meta-analysis","volume":"45","author":"Wollman","year":"2019","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.addicn.2026.100253_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.addbeh.2016.03.018","article-title":"Neurocognitive, psychiatric, and substance use characteristics in opioid dependent adults","volume":"60","author":"Arias","year":"2016","journal-title":"Addict. Behav."},{"issue":"11","key":"10.1016\/j.addicn.2026.100253_bib0009","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1016\/j.neurobiolaging.2015.07.018","article-title":"Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions","volume":"36","author":"Kovacs","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.addicn.2026.100253_bib0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2990.2005.00670.x","article-title":"Hyperphosphorylated tau and amyloid precursor protein deposition is increased in the brains of young drug abusers","volume":"31","author":"Ramage","year":"2005","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"Pt 12","key":"10.1016\/j.addicn.2026.100253_bib0011","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/brain\/awq263","article-title":"Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers","volume":"133","author":"Anthony","year":"2010","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.addicn.2026.100253_bib0012","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1038\/s41467-020-18114-3","article-title":"Chromatin accessibility mapping of the striatum identifies tyrosine kinase FYN as a therapeutic target for heroin use disorder","volume":"11","author":"Egervari","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.addicn.2026.100253_bib0013","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","article-title":"Imaging tau and amyloid-\u03b2 proteinopathies in Alzheimer disease and other conditions","volume":"14","author":"Villemagne","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"18","key":"10.1016\/j.addicn.2026.100253_bib0014","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJMoa1900757","article-title":"Tau positron-emission tomography in former national football league players","volume":"380","author":"Stern","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.addicn.2026.100253_bib0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/RLU.0000000000003261","article-title":"Clinical evaluation of 18F-PI-2620 as a potent PET radiotracer imaging tau protein in alzheimer disease and other neurodegenerative diseases Compared With 18F-THK-5351","volume":"45","author":"Oh","year":"2020","journal-title":"Clin. Nucl. Med."},{"issue":"2","key":"10.1016\/j.addicn.2026.100253_bib0016","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2967\/jnumed.117.194282","article-title":"(18)F-Flortaucipir PET\/MRI correlations in nonamnestic and amnestic variants of Alzheimer disease","volume":"59","author":"Nasrallah","year":"2018","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.addicn.2026.100253_bib0017","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2967\/jnumed.119.236224","article-title":"Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study","volume":"61","author":"Mueller","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.addicn.2026.100253_bib0018","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00259-020-04923-7","article-title":"Tau PET imaging with (18)F-PI-2620 in aging and neurodegenerative diseases","volume":"48","author":"Mormino","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. ImAging"},{"issue":"4","key":"10.1016\/j.addicn.2026.100253_bib0019","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3233\/JAD-200835","article-title":"Entorhinal tau predicts hippocampal activation and memory deficits in Alzheimer's disease","volume":"78","author":"Richter","year":"2020","journal-title":"J. Alzheimers. Dis."},{"issue":"4","key":"10.1016\/j.addicn.2026.100253_bib0020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/jamaneurol.2019.4509","article-title":"Tau positron emission tomographic findings in a former US football player with pathologically confirmed chronic traumatic encephalopathy","volume":"77","author":"Mantyh","year":"2020","journal-title":"JAMa Neurol."},{"issue":"3","key":"10.1016\/j.addicn.2026.100253_bib0021","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2018.3692","article-title":"Correlation of in vivo [18F]Flortaucipir with postmortem alzheimer disease tau pathology","volume":"76","author":"Smith","year":"2019","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.addicn.2026.100253_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112863","article-title":"Brain network segregation is associated with drug use severity in individuals with opioid use disorder","volume":"276","author":"Hager","year":"2025","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.addicn.2026.100253_bib0023","first-page":"1112","article-title":"[(11)C]Carfentanil PET whole-body imaging of \u03bc-opioid receptors: a first in-human study","volume":"66","author":"Dubroff","year":"2025","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.addicn.2026.100253_bib0024","article-title":"Mu-opioid receptor availability in patients with opioid use disorder treated with either methadone or buprenorphine","author":"Dubroff","year":"2025","journal-title":"medRxiv"},{"issue":"1","key":"10.1016\/j.addicn.2026.100253_bib0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index","volume":"168","author":"McLellan","year":"1980","journal-title":"J. Nerv. Ment. Dis."},{"issue":"2","key":"10.1016\/j.addicn.2026.100253_bib0026","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"issue":"18","key":"10.1016\/j.addicn.2026.100253_bib0027","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.1993.03500180078038","article-title":"Population-based norms for the mini-mental state examination by age and educational level","volume":"269","author":"Crum","year":"1993","journal-title":"JAMa"},{"issue":"6","key":"10.1016\/j.addicn.2026.100253_bib0028","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/1097-4679(198511)41:6<820::AID-JCLP2270410616>3.0.CO;2-X","article-title":"Estimating WAIS IQ from the shipley institute of living scale using continuously adjusted age norms","volume":"41","author":"Zachary","year":"1985","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.addicn.2026.100253_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropsychologia.2022.108415","article-title":"Effects of age on the neural correlates of encoding source and item information: An fMRI study","volume":"177","author":"Liu","year":"2022","journal-title":"Neuropsychologia"},{"issue":"12","key":"10.1016\/j.addicn.2026.100253_bib0030","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1002\/hbm.24607","article-title":"Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease","volume":"40","author":"Xie","year":"2019","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.addicn.2026.100253_bib0031","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2967\/jnumed.119.229997","article-title":"PennPET explorer: design and preliminary performance of a whole-body imager","volume":"61","author":"Karp","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.addicn.2026.100253_bib0032","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2967\/jnumed.119.231845","article-title":"PennPET explorer: human imaging on a whole-body imager","volume":"61","author":"Pantel","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.addicn.2026.100253_bib0033","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70177","article-title":"Regular use of opioids and dementia, cognitive measures, and neuroimaging outcomes among UK Biobank participants with chronic non-cancer pain","volume":"21","author":"Lin","year":"2025","journal-title":"Alzheimers. Dement."},{"issue":"2","key":"10.1016\/j.addicn.2026.100253_bib0034","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/00952990.2023.2169616","article-title":"Effects of current smoking severity on brain gray matter volume in opioid use disorder - a voxel-based morphometry study","volume":"49","author":"Shi","year":"2023","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"10","key":"10.1016\/j.addicn.2026.100253_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13336","article-title":"Hippocampal volume loss in individuals with a history of non-fatal opioid overdose","volume":"28","author":"Todaro","year":"2023","journal-title":"Addict. Biol."},{"key":"10.1016\/j.addicn.2026.100253_bib0036","doi-asserted-by":"crossref","DOI":"10.1177\/26331055241247156","article-title":"Collateral damage: neurological correlates of non-fatal overdose in the era of fentanyl-Xylazine","volume":"19","author":"Todaro","year":"2024","journal-title":"Neurosci. Insights."},{"issue":"11","key":"10.1016\/j.addicn.2026.100253_bib0037","first-page":"1748","article-title":"The overlap index as a means of evaluating early tau PET signal reliability","volume":"63","author":"Lee","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.addicn.2026.100253_bib0038","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ana.25893","article-title":"Sensitivity-specificity of tau and amyloid \u03b2 positron emission tomography in frontotemporal lobar degeneration","volume":"88","author":"Ghirelli","year":"2020","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.addicn.2026.100253_bib0039","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/WNN.0000000000000347","article-title":"Longitudinal imaging in a patient with opioid-associated amnestic syndrome","volume":"36","author":"Barash","year":"2023","journal-title":"Cogn. Behav. Neurol."}],"container-title":["Addiction Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772392526000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772392526000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:20:20Z","timestamp":1781853620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772392526000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"alternative-id":["S2772392526000052"],"URL":"https:\/\/doi.org\/10.1016\/j.addicn.2026.100253","relation":{},"ISSN":["2772-3925"],"issn-type":[{"value":"2772-3925","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hippocampal volume and brain tau pathology in opioid use disorder: Associations with non-fatal opioid overdose","name":"articletitle","label":"Article Title"},{"value":"Addiction Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addicn.2026.100253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100253"}}